SANDOZ LEVOBUNOLOL 0.5 %
LEVOBUNOLOL HYDROCHLORIDE : 0.5 % · DIN 02241716 · SANDOZ CANADA INCORPORATED
Health Canada status: CANCELLED POST MARKET
What is SANDOZ LEVOBUNOLOL?
SANDOZ LEVOBUNOLOL 0.5 % contains LEVOBUNOLOL HYDROCHLORIDE : 0.5 %. It is listed in the Health Canada Drug Product Database under DIN 02241716, held by SANDOZ CANADA INCORPORATED, supplied as LIQUID for OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 01-Aug-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02241716 |
|---|---|
| Brand name | SANDOZ LEVOBUNOLOL |
| Generic / active ingredient | LEVOBUNOLOL HYDROCHLORIDE : 0.5 % |
| Manufacturer | SANDOZ CANADA INCORPORATED |
| Strength | 0.5 % |
| Dosage form | LIQUID |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01ED03 LEVOBUNOLOL |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 01-Aug-2019 |
| Original market date | 2000-11-20 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code S01ED03 LEVOBUNOLOL. 0 of 16 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-LEVOBUNOLOL OPHTHALMIC SOLUTION USP 0.25% | 0.25 % | LIQUID | APOTEX INC | CANCELLED POST MARKET | DIN 02241575 |
| APO-LEVOBUNOLOL OPHTHALMIC SOLUTION USP 0.5% | 0.5 % | LIQUID | APOTEX INC | CANCELLED POST MARKET | DIN 02241574 |
| BETAGAN 0.5% OPHTHALMIC SOL | 0.5 % | LIQUID | ALLERGAN INC | CANCELLED POST MARKET | DIN 00637661 |
| BETAGAN OPH SOLN 0.25% | 0.25 % | LIQUID | ALLERGAN INC | CANCELLED POST MARKET | DIN 00751286 |
| LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION | 0.25 % | LIQUID | BAUSCH & LOMB PHARMACEUTICALS INC. | CANCELLED POST MARKET | DIN 02231714 |
| LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION | 0.25 % | LIQUID | ALCON CANADA INC | CANCELLED PRE MARKET | DIN 02236792 |
| LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION | 0.50 % | LIQUID | BAUSCH & LOMB PHARMACEUTICALS INC. | CANCELLED POST MARKET | DIN 02231715 |
| LEVOBUNOLOL HYDROCHLORIDE OPHTHALMIC SOLUTION | 0.50 % | LIQUID | ALCON CANADA INC | CANCELLED PRE MARKET | DIN 02236793 |
| NOVO-LEVOBUNOLOL - LIQ 0.25% | 0.25 % | LIQUID | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 02197456 |
| NOVO-LEVOBUNOLOL - LIQ 0.5% | 0.5 % | LIQUID | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 02197464 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.